NCT05566249View on ClinicalTrials.gov

A Study to Validate the Safety and Feasibility of ArtiSential in Colorectal Cancer Surgery Using Prospectively Constructed Multi-center Registry

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2029

Conditions
Rectal CancerRectosigmoid CancerRectosigmoid Junction Cancer
Interventions
DEVICE

ArtiSential

Articulating laparoscopic instrument

Trial Locations (1)

Unknown

RECRUITING

Samsung Medical Center, Seoul

Sponsors
All Listed Sponsors
collaborator

Asan Medical Center

OTHER

collaborator

Seoul St. Mary's Hospital

OTHER

collaborator

Chonnam National University Hospital

OTHER

collaborator

Severance Hospital

OTHER

collaborator

Seoul National University Bundang Hospital

OTHER

collaborator

Uijeongbu St. Mary Hospital

OTHER

collaborator

LivsMed

UNKNOWN

lead

Samsung Medical Center

OTHER

NCT05566249 - A Study to Validate the Safety and Feasibility of ArtiSential in Colorectal Cancer Surgery Using Prospectively Constructed Multi-center Registry | Biotech Hunter | Biotech Hunter